Sino Biological/VEGFR3/FLT4 cDNA开放阅读框克隆，人，N-DYKDDDDK（Flag®；）标签/1/HG10806-NF
商品编号：
HG10806-NF
品牌：
sinobiological
市场价：
¥0.00
美元价：
0.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
VEGFR3/FLT4 cDNA ORF Clone, Human, N-DYKDDDDK (Flag®) tag: General Information
Gene
Species
Human
NCBI Ref Seq
NM_002020.4
RefSeq ORF Size
3897 bp
Sequence Description
Identical with the Gene Bank Ref. ID sequence.
Description
Full length Clone DNA of Human fms-related tyrosine kinase 4 with N terminal Flag tag.
Plasmid
Promoter
Enhanced CMV promoter
Vector
pCMV3-SP-N-FLAG
Restriction Sites
HindIII + XbaI (6kb + 3.91kb)
Tag Sequence
FLAG Tag Sequence: GATTACAAGGATGACGACGATAAG
Sequencing Primers
T7( 5" TAATACGACTCACTATAGGG 3" )BGH( 5" TAGAAGGCACAGTCGAGG 3" )
Quality Control
The plasmid is confirmed by full-length sequencing.
Screening
Antibiotic in E.coli
Kanamycin
Antibiotic in Mammalian cell
Hygromycin
Application
Stable or Transient mammalian expression
Storage & Shipping
Shipping
Each tube contains lyophilized plasmid.
Storage
The lyophilized plasmid can be stored at ambient temperature for three months.
Note: Flag® is a registered trademark of Sigma Aldrich Biotechnology LP. It is used here for informational purposes only.
VEGFR3/FLT4 cDNA ORF Neucleotide Sequence and Amino Acid Sequence Information
**Sino Biological guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories.**
VEGFR3/FLT4 cDNA ORF Clone, Human, N-DYKDDDDK (Flag®) tag: Validated Images
The plasmid was transfected into 293H adherent cells with Sinofection reagent (Cat# STF02). After 48 h, Immunofluorescence staining of cells. Cells were fixed with 4% PFA, permeabilzed with 0.3% Triton X-100 in PBS, blocked with 10% serum, and incubated with Mouse anti-Flag Tag monoclonal antibody (CST#8146S) at 37℃ 1 hour. Then cells were stained with Goat Anti-mouse IgG secondary antibody. The fluorescent signal is detected by fluorescence microscope. Each expression experiment has negative control.
VEGFR3/FLT4 cDNA ORF Clone, Human, N-DYKDDDDK (Flag®) tag: Synonyms
FLT-4 cDNA ORF Clone, Human; FLT-41 cDNA ORF Clone, Human; FLT41 cDNA ORF Clone, Human; LMPH1A cDNA ORF Clone, Human; PCL cDNA ORF Clone, Human; VEGF Receptor 3 cDNA ORF Clone, Human; VEGFR-3 cDNA ORF Clone, Human; VEGFR3 cDNA ORF Clone, Human
VEGFR3/FLT4 Background Information
Vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.
- Cancer Immunotherapy
- Immune Checkpoint
- Immunotherapy
- Targeted Therapy
Full Name
fms related tyrosine kinase 4
Research Areas
- Cancer Drug Targets
- Receptor Tyrosine Kinases (RTKs)
References
- Shushanov S, et al. (2000)VEGFc and VEGFR3 expression in human thyroid pathologies. Int J Cancer.86(1): 47-52.
- Iljin K, et al. (2001) VEGFR3 gene structure, regulatory region, and sequence polymorphisms. FASEB J. 15(6): 1028-36.
- Liu XE, et al. (2004) Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol. 10(3): 352-5.
- Stearns ME, et al. (2004) Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis. Lab Invest. 84(6): 785-95.
VEGFR3/FLT4 cDNA ORF Clone, Human,Related Products
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-His tagHG10806-CH
- VEGFR3/FLT4 cDNA ORF Clone, Human, untaggedHG29697-UT
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-HA tagHG10806-CY
- VEGFR3/FLT4 cDNA ORF Clone in Cloning Vector, HumanHG10806-M
- VEGFR3/FLT4 Lentiviral cDNA ORF Clone, Human, C-GFPSpark® tagHG10806-ACGLN
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-DYKDDDDK (Flag®) tagHG29697-CF
- VEGFR3/FLT4 Lentiviral cDNA ORF Clone, Human, C-GFPSpark® tagHG29697-ACGLN
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-OFPSpark® tagHG10806-ACR
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-DYKDDDDK (Flag®) tagHG10806-CF
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-GFPSpark® tagHG10806-ACG
- VEGFR3/FLT4 cDNA ORF Clone, Human, N-HA tagHG10806-NY
- VEGFR3/FLT4 cDNA ORF Clone, Human, C-Myc tagHG10806-CM
- VEGFR3/FLT4 cDNA ORF Clone, Human, N-His tagHG10806-NH
- VEGFR3/FLT4 cDNA ORF Clone, Human, N-Myc tagHG10806-NM
- VEGFR3/FLT4 cDNA ORF Clone, Human, untaggedHG10806-UT
- Human VEGFR3/FLT4 qPCR Primer PairHP100911
VEGFR3/FLT4 cDNA ORF Clone, Mouse,Related Products
- VEGFR3/FLT4 cDNA ORF Clone in Cloning Vector, MouseMG50584-M
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, N-His tagMG50584-NH
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, N-DYKDDDDK (Flag®) tagMG50584-NF
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-HA tagMG50584-CY
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-Myc tagMG50584-CM
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, N-Myc tagMG50584-NM
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, N-HA tagMG50584-NY
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-DYKDDDDK (Flag®) tagMG50584-CF
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-GFPSpark® tagMG50584-ACG
- VEGFR3/FLT4 Lentiviral cDNA ORF Clone, Mouse, C-GFPSpark® tagMG50584-ACGLN
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-OFPSpark® tagMG50584-ACR
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, C-His tagMG50584-CH
- VEGFR3/FLT4 cDNA ORF Clone, Mouse, untaggedMG50584-UT
- Mouse VEGFR3/FLT4 qPCR Primer PairMP200662
- uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesisAuthorDurré, T;Morfoisse, F;Erpicum, C;Ebroin, M;Blacher, S;García-Caballero, M;Deroanne, C;Louis, T;Balsat, C;Van de Velde, M;Kaijalainen, S;Kridelka, F;Engelholm, L;Struman, I;Alitalo, K;Behrendt, N;Paupert, J;Noel, A;Year2018JournalNat CommunApplicationexpressionPubMed ID: 30518756FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
品牌介绍
北京义翘神州科技股份有限公司（Sino Biological Inc.）是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种，其中重组蛋白约 6,000 种，包括超过 3,800 种人源细胞表达重组蛋白产品，能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求；公司还能提供约 12,000 种抗体，其中单克隆抗体数量约 4,600 种，能够覆盖生命科学研究的多个领域，为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司，已成为生物试剂行业国内领先的科技公司之一。
联络我们
